Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Experimental Designs01:16

Experimental Designs

An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-Molecule Detection and Characterization of Non-Canonical DNA Structures With α-Hemolysin-Based Protein Nanopore Technology.

Small methods·2026
Same author

Development of a quantitative LC-MS/MS-based assay for Lycosin-II-analog 3 and assessment of its stability in biological matrices.

Talanta·2026
Same author

Nanopore-Based, Real-Time Single-Molecule Probing of i-Motif Structural Dynamics and Targeted PNA Disruption.

Nano letters·2026
Same author

Peptide PN5 from <i>Pinus densiflora</i> Confers in Vivo Protection Against Multidrug-Resistant Salmonella Typhimurium Through Membrane Disruption.

ACS omega·2026
Same author

Phosphate-Binding Zn(II)-Coordinated Antimicrobial Peptoids: Enhancing Selectivity through Specific Recognition of Bacterial Membranes.

ACS infectious diseases·2025
Same author

Pse-T2-Based Short Peptides with Broad-Spectrum Antimicrobial Activity, Stability, and Safety Combat MDR <i>Staphylococcus aureus In Vitro</i> and in Mouse Infection Model.

ACS infectious diseases·2025
Same journal

Corrigendum to: Reviewing the Context of Molecular Modeling to Enhance the Application of Machine Learning Technologies for Safer Bioinformatics.

Protein and peptide letters·2026
Same journal

Corrigendum to: A Preliminary Study on the Antibacterial Activity of the Secretion of the Levantine Water Frog, <i>Pelophylax bedriagae</i> (Camerano, 1882) (Anura:Ranidae).

Protein and peptide letters·2026
Same journal

Potent Antioxidant and Antibacterial Activities of ≤3 kDa Hydrolyzed Sarcoplasmic Proteins from IPB-D1 Chicken.

Protein and peptide letters·2026
Same journal

Hybrid 3D Bioprinted Scaffolds for the Delivery of Peptide Therapeutics.

Protein and peptide letters·2026
Same journal

Targeting α-Synuclein: Current Strategies and Emerging Therapies for Synucleinopathies.

Protein and peptide letters·2026
Same journal

Biocompatible Excipients from Microalgae: Advancing Protein and Peptide Therapeutics through Sustainable Formulation Strategies.

Protein and peptide letters·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences
08:33

A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences

Published on: September 4, 2019

Novel short AMP: design and activity study.

Yoonkyung Park1, Kyung-Soo Hahm

  • 1Research Center for Proteineous Materials, Chosun University, Gwangju 501-759, Korea.

Protein and Peptide Letters
|August 16, 2011
PubMed
Summary
This summary is machine-generated.

A novel peptide, HP (4-16)-W, derived from Helicobacter pylori Ribosomal Protein L1 (RPL1), shows enhanced antimicrobial and antitumor activity. This peptide is a promising candidate for developing new antibiotic agents without causing hemolysis.

More Related Videos

Novel Object Exploration as a Potential Assay for Higher Order Repetitive Behaviors in Mice
08:28

Novel Object Exploration as a Potential Assay for Higher Order Repetitive Behaviors in Mice

Published on: August 20, 2016

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

Related Experiment Videos

Last Updated: May 30, 2026

A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences
08:33

A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences

Published on: September 4, 2019

Novel Object Exploration as a Potential Assay for Higher Order Repetitive Behaviors in Mice
08:28

Novel Object Exploration as a Potential Assay for Higher Order Repetitive Behaviors in Mice

Published on: August 20, 2016

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

Area of Science:

  • Microbiology
  • Peptide Chemistry
  • Drug Discovery

Background:

  • Previous research demonstrated that the truncated peptide HP (4-16) exhibits antibiotic properties without hemolysis.
  • The N-terminal region of Helicobacter pylori Ribosomal Protein L1 (RPL1) is a source for developing antimicrobial agents.

Purpose of the Study:

  • To design and synthesize a novel analogue of HP (4-16) with enhanced hydrophobicity for improved therapeutic potential.
  • To evaluate the antimicrobial and antitumor activities of the designed peptide analogue.

Main Methods:

  • Peptide synthesis: An analogue, HP (4-16)-W, was created by substituting Tryptophan (Trp) at position 2.
  • Antimicrobial assays: Growth inhibitory effects were tested against various bacterial and fungal strains, including S. aureus, E. coli, P. aeruginosa, C. albicans, and S. cerevisiae.
  • Hemolysis assay: The peptide's hemolytic activity was assessed using human erythrocyte cells.

Main Results:

  • The synthetic peptide HP (4-16)-W demonstrated enhanced antimicrobial activity against a broad spectrum of pathogens.
  • HP (4-16)-W also exhibited significant antitumor activity.
  • No hemolytic activity was observed for HP (4-16)-W against human erythrocytes, unlike the positive control, melittin.

Conclusions:

  • HP (4-16)-W is a potent antimicrobial and antitumor agent with a favorable safety profile.
  • This peptide represents a promising lead compound for the development of novel therapeutic drugs.
  • The findings support the potential of modified RPL1-derived peptides as new antibiotic agents.